# Combined intraarterial 5‐fluorouracil and subcutaneous interferon‐α therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/combined-intraarterial-5-fluorouracil-and-subcutaneous-interferon-therapy-for/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Masato Sakon,Hiroaki Nagano,Keizo Dono,Shoji Nakamori,Koji Umeshita,Akira Yamada,Sumio Kawata,Yasuharu Imai,Shöhei Iijima,Morito Monden |
| Citations | 203 |
| DOI | 10.1002/cncr.10246 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2016018273 |
| PMID | 11900229 |
| Type | article |
| Year | 2002 |

## Paper authors

- [Akira Yamada](https://scholariq.org/researchers/akira-yamada/)

## Paper journal

- [Cancer](https://scholariq.org/journals/cancer/)

## Paper primary topic

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)

## Paper topics

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)
- [Liver Disease and Transplantation](https://scholariq.org/topics/liver-disease-and-transplantation/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.